Psychosis in Fabry disease and treatment with phenoxybenzamine.
D000328:Adult; D001626:Bethanechol Compounds / Q000627:therapeutic use; D006017:Glycolipids / Q000378:metabolism*; D006801:Humans; D008052:Lipid Metabolism, Inborn Errors / Q000150:complications*; D008297:Male; D019965:Neurocognitive Disorders / Q000150:complications* / Q000188:drug therapy; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D010672:Phenytoin / Q000627:therapeutic use; D012075:Remission, Spontaneous
D001626:Bethanechol Compounds; D006017:Glycolipids; D010643:Phenoxybenzamine; D010672:Phenytoin